SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-130708
Filing Date
2016-11-01
Accepted
2016-11-01 07:11:19
Documents
56
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v450745_10q.htm 10-Q 431608
2 EXHIBIT 31.1 v450745_ex31-1.htm EX-31.1 12541
3 EXHIBIT 31.2 v450745_ex31-2.htm EX-31.2 12410
4 EXHIBIT 32.1 v450745_ex32-1.htm EX-32.1 4883
5 EXHIBIT 32.2 v450745_ex32-2.htm EX-32.2 4863
6 GRAPHIC image_001.jpg GRAPHIC 39814
  Complete submission text file 0001144204-16-130708.txt   3668925

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20160930.xml EX-101.INS 864106
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20160930.xsd EX-101.SCH 38209
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20160930_cal.xml EX-101.CAL 33964
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20160930_def.xml EX-101.DEF 202502
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20160930_lab.xml EX-101.LAB 264394
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20160930_pre.xml EX-101.PRE 235768
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 161963239
SIC: 2834 Pharmaceutical Preparations